Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APTX
3076
DELISTED
Aptinyx Inc. Common Stock
APTX
| $597K | ﹤0.01% |
262,926
-100
| -0% | -$300 |
|
|
AAN
3077
DELISTED
The Aaron's Company Inc
AAN
| $596K | ﹤0.01% |
29,700
-53,400
| -64% | -$1.17M |
|
|
APLT
3078
DELISTED
Applied Therapeutics
APLT
| $595K | ﹤0.01% |
282,200
+264,600
| +1,503% | +$709K |
|
3079
Ramaco Resources Class A
METC
$777M
| $594K | ﹤0.01% |
38,863
+9,922
| +34% | +$145K |
|
|
ATYR
3080
aTyr Pharma
ATYR
$54.8M
| $593K | ﹤0.01% |
110,855
-16,300
| -13% | -$92.4K |
|
3081
Carpenter Technology
CRS
$27.1B
| $592K | ﹤0.01% |
14,100
-68,700
| -83% | -$2.4M |
|
3082
Traws Pharma
TRAW
$8.7M
| $592K | ﹤0.01% |
12,870
+7,525
| +141% | +$349K |
|
|
SFBS
3083
ServisFirst Bancshares
SFBS
$4.99B
| $591K | ﹤0.01% |
+6,200
| New | +$541K |
|
|
SDPI
3084
DELISTED
Superior Drilling Products Inc.
SDPI
| $591K | ﹤0.01% |
557,330
-536,800
| -49% | -$506K |
|
3085
ProShares Ultra S&P500
SSO
$8.47B
| $590K | ﹤0.01% |
18,000
-106,400
| -86% | -$3.41M |
|
3086
Unity Bancorp
UNTY
$621M
| $590K | ﹤0.01% |
21,080
-29,624
| -58% | -$847K |
|
3087
Virco
VIRC
$95.2M
| $589K | ﹤0.01% |
196,868
-13,000
| -6% | -$39.3K |
|
|
FFBW
3088
DELISTED
FFBW, Inc. Common Stock
FFBW
| $589K | ﹤0.01% |
48,745
-1,781
| -4% | -$21.4K |
|
|
CIZN
3089
DELISTED
Citizens Holding Co.
CIZN
| $589K | ﹤0.01% |
30,435
+500
| +2% | +$9.16K |
|
3090
AptarGroup
ATR
$8.4B
| $588K | ﹤0.01% |
+5,000
| New | +$588K |
|
3091
CVD Equipment Corp
CVV
$56M
| $588K | ﹤0.01% |
131,182
-24,200
| -16% | -$108K |
|
3092
Cytek Biosciences
CTKB
$610M
| $585K | ﹤0.01% |
54,300
-54,700
| -50% | -$739K |
|
3093
Columbus McKinnon
CMCO
$556M
| $584K | ﹤0.01% |
13,785
-12,600
| -48% | -$569K |
|
3094
Universal Logistics Holdings
ULH
$509M
| $584K | ﹤0.01% |
29,000
-33,200
| -53% | -$628K |
|
3095
Wolverine World Wide
WWW
$1.72B
| $584K | ﹤0.01% |
25,891
+2,892
| +13% | +$72.1K |
|
|
CTO
3096
CTO Realty Growth
CTO
$825M
| $581K | ﹤0.01% |
26,301
-45,900
| -64% | -$947K |
|
3097
iShares National Muni Bond ETF
MUB
$45.8B
| $581K | ﹤0.01% |
+5,300
| New | +$598K |
|
|
DLA
3098
DELISTED
Delta Apparel Inc.
DLA
| $581K | ﹤0.01% |
19,500
-22,800
| -54% | -$681K |
|
|
ORTX
3099
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $580K | ﹤0.01% |
81,403
-16,198
| -17% | -$159K |
|
|
NRGD
3100
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
| $577K | ﹤0.01% |
+519
| New | +$930K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.